UNICA IRIS Institutional Research Information System

DE LOGU, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 173.492
NA - Nord America 10.470
AS - Asia 4.766
SA - Sud America 698
Continente sconosciuto - Info sul continente non disponibili 256
AF - Africa 108
Totale 189.790
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 169.834
US - Stati Uniti d'America 10.265
SG - Singapore 1.883
CN - Cina 1.803
UA - Ucraina 1.050
DE - Germania 611
SE - Svezia 607
FI - Finlandia 560
BR - Brasile 509
VN - Vietnam 350
GB - Regno Unito 301
FR - Francia 278
HK - Hong Kong 140
BD - Bangladesh 119
IN - India 119
KR - Corea 113
CA - Canada 105
MX - Messico 71
AR - Argentina 51
MA - Marocco 46
RU - Federazione Russa 44
EC - Ecuador 42
NL - Olanda 42
IQ - Iraq 38
CO - Colombia 28
JP - Giappone 27
TR - Turchia 25
BE - Belgio 22
ES - Italia 22
ID - Indonesia 22
PL - Polonia 22
PE - Perù 19
ZA - Sudafrica 19
PK - Pakistan 18
VE - Venezuela 15
UZ - Uzbekistan 12
CH - Svizzera 11
CL - Cile 11
IE - Irlanda 11
MD - Moldavia 11
PH - Filippine 11
SA - Arabia Saudita 11
AT - Austria 10
IL - Israele 10
PY - Paraguay 10
EG - Egitto 9
KE - Kenya 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
JM - Giamaica 7
TN - Tunisia 7
AL - Albania 6
AZ - Azerbaigian 6
EU - Europa 6
JO - Giordania 6
BO - Bolivia 5
DZ - Algeria 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
BY - Bielorussia 4
DK - Danimarca 4
HU - Ungheria 4
KZ - Kazakistan 4
PT - Portogallo 4
SM - San Marino 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
GE - Georgia 3
LT - Lituania 3
MU - Mauritius 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CG - Congo 2
CU - Cuba 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 189.526
Salva come PNG Salva come JPEG
Città #
Cagliari 165.205
Uta 3.055
Singapore 865
Ashburn 774
Chandler 764
San Jose 701
Woodbridge 635
Fairfield 625
Jacksonville 597
Boardman 590
Ann Arbor 491
Dallas 459
Houston 409
Nyköping 406
Helsinki 403
Wilmington 328
Beijing 269
Seattle 259
Munich 257
New York 257
Los Angeles 225
Cambridge 214
Hefei 209
Boston 181
Nanjing 162
Council Bluffs 155
Santa Clara 146
Lauterbourg 139
Hong Kong 127
Dearborn 125
Ho Chi Minh City 117
Milan 116
Seoul 112
Buffalo 91
Rome 89
The Dalles 87
Shanghai 85
Hanoi 79
Redwood City 68
Chicago 67
Shenyang 61
Toronto 60
Nanchang 59
Tianjin 57
Verona 52
Hebei 49
Changsha 45
São Paulo 45
Guangzhou 36
San Diego 35
Atlanta 33
Jiaxing 33
Casablanca 31
Orange 30
Chennai 28
London 28
Washington 28
Zhengzhou 28
Columbus 27
Jinan 26
Orem 25
Norwalk 23
Brooklyn 22
Ningbo 21
Bologna 20
Florence 20
Redondo Beach 19
Tokyo 19
Brussels 18
Naples 17
Nuremberg 17
Elk Grove Village 16
Phoenix 16
Quito 16
Rio de Janeiro 16
Frankfurt am Main 15
Hangzhou 15
Sassari 15
Warsaw 15
Auburn Hills 14
Dhaka 14
Genoa 14
Johannesburg 14
Haiphong 13
Mountain View 13
Salt Lake City 13
Palermo 12
Saint Petersburg 12
San Francisco 12
Baghdad 11
Caserta 11
Catania 11
Curitiba 11
Da Nang 11
Denver 11
Jyväskylä 11
Pune 11
Turin 11
Turku 11
Amsterdam 10
Totale 181.330
Salva come PNG Salva come JPEG
Nome #
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.068
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.611
Limonoids from Melia azedarach fruits as inhibitors of flaviviruses and mycobacterium tubercolosis 4.495
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.420
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases 3.504
Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells 3.072
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 2.774
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 2.382
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 2.344
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 2.288
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action. 2.256
Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection 2.221
Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach 2.204
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.188
HPLC-DAD-MS analysis and antiviral activity of different extracts and isolated costituents from Bituminaria bituminosa 2.171
Imidazole and 1,2,4-triazole-based derivatives gifted with antitubercular activity: Cytotoxicity and computational assessment 2.117
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.116
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis 2.115
Improving the physical chemical properties of a very promising class of pyrrole antimycobacterial agents 2.061
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 2.025
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 2.011
In vivo potent BM635 analogue with improved drug-like properties 1.993
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis and microbiological evaluation 1.977
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation 1.975
null 1.953
null 1.949
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones 1.945
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.942
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug 1.931
null 1.829
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings 1.827
Nuove strategie per lo sviluppo di farmaci antitubercolari: caratterizzazione di target alternativi e di fattori di virulenza in Mycobacterium tuberculosis 1.809
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: Preliminary data and computational analysis 1.805
Sherris. Microbiologia medica 1.783
null 1.749
Individuazione di nuovi target in MDR e XDR Mycobacterium tuberculosis mediante 1,5-difenil- e 1,5-diaril-2-etil-pirroli per lo sviluppo di nuovi agenti antitubercolari 1.692
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.676
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.670
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.654
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis 1.628
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.601
Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.570
Phenazine-1-carboxilyc acid derivatives suppressing the RNA polymerase as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.561
Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis 1.536
Effetto di Inibitori delle COX-1 e COX-2 sullo sviluppo del biofilm di Candida albicans: studio della associazione di FANS e derivati azolici per la profilassi delle infezioni fungine contratte in ambiente ospedaliero 1.495
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 1.490
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.480
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.470
dentification of a new Chemical Class of Potent Antimycobacterial Compounds 1.451
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 1.438
Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis 1.421
Design, synthesis and microbiological characterization of 1,5-diphenyl and 1,5-diaryl-2-ethylpyrrole derivatives as new potential agents of infections sustained by MDR and XDR Mycobacterium tuberculosis. 1.374
Nuovo sistema di fermentazione in semi-solido per la produzione di enzimi cellulosolitici 1.363
Sul trattamento microbiologico delle acque di vegetazione 1.300
Infezioni nosocomiali da Pseudomonas maltophilia in un reparto di terapia intensiva per neonat 1.296
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.281
Saggi e dosaggi microbiologici della Farmacopea 1.262
Effetto di FANS sulla formazione di biofilm di Candida albicans e potenziamento della attività di farmaci antifungini 1.252
Studio di un metodo rapido mediante riduzione di XTT per la determinazione della resistenza in Mycobacterium tuberculosis 1.236
BM212 and its derivatives: lead optimization of a new class of antimycobacterial agents. 1.209
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action 1.176
null 1.144
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.138
Antimycobacterial Activiy of New 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues 1.133
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents.Design, synthesis, biological evaluation and study of their mode of action. 1.122
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 1.099
null 1.070
In vitro antiviral activity of liposomal Artemisia arborescens essential oil 1.052
Derivatives of BM 212: synthesis and biological evaluation of new derivatives with improved antimycobacterial activity. 1.049
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 1.047
New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials. 1.021
L’OLIO ESSENZIALE DI ARTEMISIA ARBORESCENS INATTIVA HSV1 E HSV2 E INIBISCE LA DIFFUSIONE LATERALE DI CELLULE VERO 1.017
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 984
null 935
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 918
PHISICAL STABILITY OF ARTEMISIA ARBORESCENS L. ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 917
Influenza dell'inclusione liposomiale sull'attività in vitro di miconazolo e ketoconazolo 876
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 830
null 826
Effetti dei liposomi sull'attività in vitro di alcuni antifungini 821
null 818
L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero 808
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 772
null 764
Aspetti Microbiologici della Produzione Farmaceutica 761
null 736
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 717
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 710
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 697
Liposomes as carrier for Artemisia arborescens essential oil: preparation, characterisation and antiviral activity 676
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis 672
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 661
Degradazione biologica degli aghi di pino (Pinus Silvester) 657
Attività intramacrofagica di nuovi agenti antitubercolari per il trattamento delle infezioni sostenute da ceppi MDR mediante inibizione selettiva della RNA polimerasi. 651
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 632
Saggi e dosaggi microbiologici della Farmacopea 624
Aspetti microbiologici della produzione farmaceutica 622
null 605
Stafilococchi 592
PHYSICAL STABILITY OF ARTEMISIA ARBORESCENS ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 590
Totale 155.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 249.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 249.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.459 0 908 478 567 715 541 389 529 756 769 902 905
2022/202312.524 1.314 1.647 1.447 886 818 1.183 645 1.462 742 620 954 806
2023/202416.879 940 523 1.037 1.211 1.661 3.247 2.625 943 684 1.201 1.491 1.316
2024/202534.953 7.713 11.595 4.674 2.829 1.715 1.663 2.824 277 451 317 443 452
2025/20269.830 490 699 1.088 1.127 500 599 1.264 1.104 663 1.142 685 469
2026/2027727 438 289 0 0 0 0 0 0 0 0 0 0
Totale 189.790